<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05610007</url>
  </required_header>
  <id_info>
    <org_study_id>IndonesiaUAnes125</org_study_id>
    <nct_id>NCT05610007</nct_id>
  </id_info>
  <brief_title>Comparison of Hyperbaric Prilocaine 2% 50 Mg and Hyperbaric Bupivacaine 0.5% 12.5 Mg Against Spinal Anesthesia Recovery Time in Cystoscopy Procedure</brief_title>
  <official_title>Comparison of Hyperbaric Prilocaine 2% 50 Mg and Hyperbaric Bupivacaine 0.5% 12.5 Mg Against Spinal Anesthesia Recovery Time in Cystoscopy Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Data regarding the comparison of recovery time from spinal anesthesia between prilocaine and&#xD;
      bupivacaine are still relatively limited. The aim of this study was to compare the speed of&#xD;
      recovery of spinal anesthesia with hyperbaric prilocaine 2% 50 mg compared to hyperbaric&#xD;
      bupivacaine 0.5% 12.5 mg in cystoscopy procedures. By knowing the speed of recovery time, it&#xD;
      is hoped that the patient will recover faster, be transferred to the treatment room faster,&#xD;
      be safer, and the length of treatment will be shorter so that the quality of service for&#xD;
      cystoscopy procedures and patient satisfaction is getting better.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a double-blind randomized clinical trial. This study compared the speed of&#xD;
      recovery from spinal anesthesia, as many as 66 subjects were divided into two groups, namely&#xD;
      hyperbaric prilocaine 2% 50 mg and hyperbaric bupivacaine 0.5% 12.5 mg who would undergo a&#xD;
      cystoscopy procedure. This research was conducted in the urological surgery room of RSCM in&#xD;
      January - October 2022, after passing the ethical review and obtaining a location permit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2022</start_date>
  <completion_date type="Anticipated">November 1, 2022</completion_date>
  <primary_completion_date type="Actual">August 1, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog scale (VAS)</measure>
    <time_frame>24 hour</time_frame>
    <description>Pain measurement scale felt by patients with a score of 0 = no pain and a score of 10 = unbearable severe pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complication</measure>
    <time_frame>24 hour</time_frame>
    <description>Complications that occur due to spinal drug administration, such as chills, hypotension, postoperative nausea and vomiting.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Anesthesia</condition>
  <condition>Anesthesia; Reaction</condition>
  <arm_group>
    <arm_group_label>Prilocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50 mg hyperbaric 2% prilocaine (2.5 ml volume) + 25 mcg fentanyl (0.5 ml volume)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12.5, 5 mg hyperbaric 0.5% bupivacaine (2.5 ml volume) + 25 mcg fentanyl (0.5 ml volume)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prilocaine</intervention_name>
    <description>Patients in the prilocaine group were given 50 mg hyperbaric 2% prilocaine (2.5 ml volume) + 25 mcg fentanyl (0.5 ml volume) before undergoing the cystoscopy procedure.</description>
    <arm_group_label>Prilocaine</arm_group_label>
    <arm_group_label>bupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female over the age of 18,&#xD;
&#xD;
          -  ASA physical status I - III,&#xD;
&#xD;
          -  Normal body mass index according to Quetelet's index,&#xD;
&#xD;
          -  Willing to be a research participant and comply with the research rules.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have a history of allergy to prilocaine or bupivacaine,&#xD;
&#xD;
          -  Have a previous history of walking disorders&#xD;
&#xD;
          -  Spinal anesthesia is contraindicated.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cipto Mangunkusumo Cental National Hospital</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 2, 2022</study_first_submitted>
  <study_first_submitted_qc>November 2, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2022</study_first_posted>
  <last_update_submitted>November 2, 2022</last_update_submitted>
  <last_update_submitted_qc>November 2, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Aida Rosita Tantri</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prilocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

